Portfolio (Quarterly)
Guide ↗
GILEAD SCIENCES, INC.
· CIK 0000882095| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RCUS | ARCUS BIOSCIENCES INC | Healthcare | 31,424,760.0 | $748.9M | 38.69% | — | — | $23.83 | -1.7% |
| 2 | GLPG | GALAPAGOS NV | Healthcare | 16,707,477.0 | $550.6M | 28.45% | — | — | $32.96 | -16.6% |
| 3 | ACLX | ARCELLX INC | Healthcare | 6,720,803.0 | $438.2M | 22.64% | — | — | $65.20 | +76.5% |
| 4 | — | ASSEMBLY BIOSCIENCES INC | — | 4,505,391.0 | $153.2M | 7.92% | — | — | $34.01 | — |
| 5 | KYTX | KYVERNA THERAPEUTICS INC | Healthcare | 4,126,119.0 | $38.8M | 2.00% | — | — | $9.40 | -7.8% |
| 6 | — | XILIO THERAPEUTICS INC | — | 9,105,451.0 | $5.8M | 0.30% | — | — | $0.64 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%